David S. Weiss

机构：Emory Healthcare, Emory University · ORCID：0000-0003-0980-7866

发表论文 133 篇 · 总被引 22068 次 · h-index 47

代表论文

• Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement (2023 · Science Translational Medicine · 被引 120)
• Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens (2021 · The Lancet Infectious Diseases · 被引 112)
• Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant Enterobacterales in the United States (2021 · mBio · 被引 66)
• Heteroresistance to beta-lactam antibiotics may often be a stage in the progression to antibiotic resistance (2021 · PLoS Biology · 被引 61)
• Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections (2024 · Nature Medicine · 被引 58)
• Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results? (2021 · The Lancet Microbe · 被引 39)